These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 2188506)

  • 41. Reduced natriuretic effect of atrial natriuretic peptide in nephrotic syndrome: a possible role of decreased cyclic guanosine monophosphate.
    Jespersen B; Eiskjaer H; Mogensen CE; Sørensen SS; Pedersen EB
    Nephron; 1995; 71(1):44-53. PubMed ID: 8538848
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of aldosterone in the antihypertensive effect of spironolactone in essential hypertension.
    Benraad H; Drayer J; Hoefnagels W; Kloppenborg P; Benraad T
    Clin Pharmacol Ther; 1978 Dec; 24(6):638-43. PubMed ID: 710023
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Functional relationships in the nephrotic syndrome.
    Geers AB; Koomans HA; Roos JC; Boer P; Dorhout Mees EJ
    Kidney Int; 1984 Sep; 26(3):324-30. PubMed ID: 6392692
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of renal nerves in renal sodium retention of nephrotic syndrome.
    Herman PJ; Sawin LL; DiBona GF
    Am J Physiol; 1989 May; 256(5 Pt 2):F823-9. PubMed ID: 2719117
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Plasma active and inactive renin and urinary kallikrein in normal subjects in response to hydrochlorothiazide, spironolactone or aldosterone administration.
    Rappelli A; Dessì-Fulgheri P; Madeddu P; Leoni C; Fiori C; Cocco F; Sanna G; Glorioso N
    Clin Exp Hypertens A; 1982; 4(11-12):2273-83. PubMed ID: 6756696
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evidence that some mechanism other than the renin system causes sodium retention in nephrotic syndrome.
    Brown EA; Markandu ND; Sagnella GA; Squires M; Jones BE; MacGregor GA
    Lancet; 1982 Dec; 2(8310):1237-40. PubMed ID: 6128546
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dihydrospirorenone, a new progestogen with antimineralocorticoid activity: effects on ovulation, electrolyte excretion, and the renin-aldosterone system in normal women.
    Oelkers W; Berger V; Bolik A; Bähr V; Hazard B; Beier S; Elger W; Heithecker A
    J Clin Endocrinol Metab; 1991 Oct; 73(4):837-42. PubMed ID: 1890155
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Studies on diurnal blood pressure variation in kidney diseases associated with excessive salt and water retention.
    Barenbrock M; Spieker C; Hausberg M; Rahn KH; Zidek W; Kisters K
    J Hum Hypertens; 1999 Apr; 13(4):269-73. PubMed ID: 10333346
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Renin-angiotensin-aldosterone system in nephrotic syndrome.
    Hammond TG; Whitworth JA; Saines D; Thatcher R; Andrews J; Kincaid-Smith P
    Am J Kidney Dis; 1984 Jul; 4(1):18-23. PubMed ID: 6377881
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Defective renal water excretion in nephrotic syndrome: the relationship between renal water excretion and kidney function, arginine vasopressin, angiotensin II and aldosterone in plasma before and after oral water loading.
    Pedersen EB; Danielsen H; Madsen M; Jensen T
    Eur J Clin Invest; 1985 Feb; 15(1):24-9. PubMed ID: 3921381
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sodium retention and volume expansion in nephrotic syndrome: implications for hypertension.
    Ray EC; Rondon-Berrios H; Boyd CR; Kleyman TR
    Adv Chronic Kidney Dis; 2015 May; 22(3):179-84. PubMed ID: 25908466
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A study of the renin-angiotensin system in the nephrotic syndrome.
    Medina A; Davies DL; Brown JJ; Fraser R; Lever AF; Mallick NP; Morton JJ; Robertson JI; Tree M
    Nephron; 1974; 12(4):233-40. PubMed ID: 4366110
    [No Abstract]   [Full Text] [Related]  

  • 53. Acid-base and endocrine effects of aldosterone and angiotensin II inhibition in metabolic acidosis in human patients.
    Henger A; Tutt P; Riesen WF; Hulter HN; Krapf R
    J Lab Clin Med; 2000 Nov; 136(5):379-89. PubMed ID: 11079465
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of extremely high sodium intake on plasma renin activity, plasma aldosterone concentration, and urinary excretion of aldosterone metabolites.
    Pratt JH; Luft FC
    J Lab Clin Med; 1979 May; 93(5):724-9. PubMed ID: 429871
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of spironolactone in hypertensive patients on regular haemodialysis and after renal allotransplantation.
    Papadimitriou M; Vyzantiadis A; Milionis A; Memmos D; Metaxas P
    Life Support Syst; 1983; 1(3):197-205. PubMed ID: 6433115
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization of a group of essential hypertensives with impaired regulation of aldosterone.
    Wambach G; Helber A; Bönner G; Konrads A; Hummerich W; Meurer KA; Kaufmann W
    Clin Exp Hypertens A; 1982; 4(9-10):1835-49. PubMed ID: 6754153
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The influence of enalapril or spironolactone on experimental cyclosporin nephrotoxicity.
    McAuley FT; Whiting PH; Thomson AW; Simpson JG
    Biochem Pharmacol; 1987 Mar; 36(5):699-703. PubMed ID: 3030332
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of amlodipine on urinary sodium excretion, renin-angiotensin-aldosterone system, atrial natriuretic peptide and blood pressure in essential hypertension.
    Cappuccio FP; Markandu ND; Sagnella GA; Singer DR; Buckley MG; Miller MA; MacGregor GA
    J Hum Hypertens; 1991 Apr; 5(2):115-9. PubMed ID: 1830107
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Time-course of sodium transport along the nephron in nephrotic syndrome: The role of potassium.
    Dizin E; Olivier V; Maire C; Komarynets O; Sassi A; Roth I; Loffing J; de Seigneux S; Maillard M; Rutkowski JM; Edwards A; Feraille E
    FASEB J; 2020 Feb; 34(2):2408-2424. PubMed ID: 31908015
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of aldosterone in the control of sodium excretion in patients with advanced chronic renal failure.
    Berl T; Katz FH; Henrich WL; de Torrente A; Schrier RW
    Kidney Int; 1978 Sep; 14(3):228-35. PubMed ID: 723150
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.